Back to Self-Funded Mastery

Published: 2026-11-11 | By Paul H. Flowers Jr.

A PBM Audit Right Is Not an Audit Plan

A pharmacy-benefit contract can give an employer the right to audit. That sounds reassuring. It is not the same thing as having a disciplined way to use the right.

Without a calendar, a decision owner, defined records, and a plan for acting on findings, audit language can sit in a contract until renewal or a cost spike makes the review urgent. By then, the useful questions are harder to answer and the choices narrower.

The source idea: PBM transparency is becoming a recurring review

In its October 2026 final rule on pharmacy benefit manager fee disclosure, the U.S. Department of Labor described initial and ongoing compensation disclosures for covered service providers to large self-insured plans. It also describes annual audit rights and ongoing disclosure periods, with quarterly information available if the plan requests it. The specific requirements generally apply for plan years beginning on or after July 1, 2027.

The rule is regulatory context, not a substitute for advice on a particular plan. The management lesson is simpler: when information is meant to be compared over time, the employer needs a repeatable review process rather than a one-time document request.

Turn contract language into a work plan

Start by naming the people who will receive the information, ask the questions, and preserve the record. A benefits leader may coordinate the work. Finance may test budget impact. A committee or named fiduciary may need to evaluate the arrangement. Counsel, an advisor, or an independent auditor may have a role depending on the plan and the issue. Titles vary; accountability should not.

Next, decide what will be compared. A useful pharmacy review can track the compensation described before a renewal against amounts that appear during the year. It can also identify formulary changes, specialty-drug trends, pharmacy-channel shifts, member disruption, and the contract terms that explain movement. The aim is not to treat every variance as misconduct. It is to know which variance needs an explanation before it becomes a surprise.

Ask for evidence early enough to use it

Waiting until a renewal presentation turns the review into a negotiation scramble. A Midwest employer with a January renewal may need its pharmacy questions and data schedule settled months earlier so leadership can consider alternatives without rushing employees or vendors.

The final rule’s framework makes the timing point concrete: initial disclosures are intended to arrive ahead of a contract, renewal, or extension, while ongoing disclosures create an opportunity to compare expectations with actual experience. A report that arrives after the decision is made may be informative, but it is not decision support.

Make the review usable for leadership

Paul H. Flowers Jr. at Superior Insurance Advisors and Paul.Health helps employers translate health-plan vendor materials into a practical decision file: what the plan bought, what the data shows, what remains unknown, and who owns the next question. For pharmacy benefits, the strongest audit clause is still only a starting point. The working asset is a review process that exists before the pressure arrives.

Source: U.S. Department of Labor, “Pharmacy Benefit Manager Fee Disclosure Final Rule”, October 2026, accessed November 11, 2026. This article is original educational commentary, not legal, tax, investment, or fiduciary advice. The final rule, plan documents, contracts, and applicable law govern.

Five questions for the next pharmacy review

If your PBM audit right became necessary next quarter, does your team already have a calendar, an owner, and a defined question to test?